Luminary Therapeutics: Funding, Investors & Team (Sep 2026)
Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We have multiple solid tumor targets under development with a proprietary signaling method to ensure T-Cell persistence. Additionally, our Ligand BAFF CAR for hematologic cancers is designed with 3 antigen receptors specifically designed to overcome antigen escape. For more information visit www.luminarytx.com
Luminary Therapeutics has raised $6.1M across 2 funding rounds on record, the most recent an undisclosed round of $5.8M announced in Mar 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Luminary Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Luminary Therapeutics Funding Rounds
Luminary Therapeutics raised $300k in an undisclosed round announced in Oct 2024.
5 months later, an undisclosed round of $5.8M was announced in Mar 2025.
Luminary Therapeutics Founders and Leadership Team
Contact details for the Luminary Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Luminary Therapeutics Funding Compared to Other Biotechnology Startups
Luminary Therapeutics' latest round of $5.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Luminary Therapeutics in Biotechnology and Minneapolis
Companies Similar to Luminary Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Luminary Therapeutics Funding FAQs
What does Luminary Therapeutics do?
Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We have multiple solid tumor targets under development with a proprietary signaling method to ensure T-Cell persistence. Additionally, our Ligand BAFF CAR for hematologic cancers is designed with 3 antigen receptors specifically designed to overcome antigen escape. For more information visit www.luminarytx.com
How much funding has Luminary Therapeutics raised?
Luminary Therapeutics has raised $6.1M across 2 rounds on record. The most recent is an undisclosed round of $5.8M announced in Mar 2025.
When did Luminary Therapeutics last raise funding?
Luminary Therapeutics' most recent funding round on record is an undisclosed round of $5.8M, announced in Mar 2025.
Who founded Luminary Therapeutics?
FundedIQ lists Beau Webber (Founder) at Luminary Therapeutics.
Where is Luminary Therapeutics headquartered?
Luminary Therapeutics is based in Minneapolis, Minnesota, United States.
How many employees does Luminary Therapeutics have?
Luminary Therapeutics is in the 1-10 employee band.
How does Luminary Therapeutics' funding compare to other Biotechnology startups?
Luminary Therapeutics' latest round of $5.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Luminary Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Luminary Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.